Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Standing diastolic blood pressure"'
Publikováno v:
Postgraduate Medical Journal. 66:616-621
Summary An 8-week combination low sodium, low fat, high fibre diet was compared to the individual components of this diet in a controlled trial using 193 patients already on treatment for essential hypertension. No significant changes were observed i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d4b8f9d7db55014b7f18d464fb2ebd4
https://doi.org/10.1136/pgmj.66.778.616
https://doi.org/10.1136/pgmj.66.778.616
Publikováno v:
Drugs. 40:26-29
Isradipine, a new calcium antagonist, was administered to 51 Pakistani patients with hypertension (36 women, 15 men; mean age 47 years) over an 8-week period. Mean sitting systolic, and sitting and standing diastolic blood pressure was significantly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a7c4b7e82c6f4f2f322c4cbd4d5c2ee
https://doi.org/10.2165/00003495-199000402-00008
https://doi.org/10.2165/00003495-199000402-00008
Autor:
John Manos
Publikováno v:
American heart journal. 121(1 Pt 2)
This study assessed the long-term (54 weeks) antihypertensive efficacy and safety of doxazosin in the treatment of mild or moderate essential hypertension, defined as sitting and standing diastolic blood pressure of 95 to 114 mm Hg. Of the 153 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4d0dcec265beabbad9a4625a30a39e7
https://pubmed.ncbi.nlm.nih.gov/1824659
https://pubmed.ncbi.nlm.nih.gov/1824659
Publikováno v:
Clinical Pharmacology and Therapeutics. 30:57-63
Renal function studies were performed in subjects with mild hypertension treated with labetalol (n = 5) and moderate to moderately severe hypertension treated in a random double-blind fashion with either labetalol (n = 6) or methyldopa (n = 6). Drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a9e2242ecb50b952bb305c4cc6cb32d
https://doi.org/10.1038/clpt.1981.127
https://doi.org/10.1038/clpt.1981.127
Publikováno v:
Clinical Pharmacology & Therapeutics. 19:325-332
Oxprenolol, a beta-blocker, is an effective antihypertensive when administered 3 or 4 times daily. We evaluated the antihypertensive effect of oxprenololgiven twice daily (bid). The subjects were 15 ambulatory men whose standing diastolic blood press
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06fd26c68f329ca415c92f974ed8947c
https://doi.org/10.1002/cpt1976193325
https://doi.org/10.1002/cpt1976193325
Publikováno v:
Clinical Science. 51:617s-619s
1. Two vasodilators, prazosin and hydrallazine, have been compared in three double-blind cross-over studies designed to test their effect when used in combination with a β-adrenoceptor-blocking agent and a thiazide. 2. Single doses of 3 mg of prazos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fe6ccaf39afe7e636532de227f32cf3
https://doi.org/10.1042/cs051617s
https://doi.org/10.1042/cs051617s